Hyundai Motor Co. sold 49,815 units of Creta in India between January and April, up by 248 percent from the same period in 2020, to become the country's top-selling SUV.
Creta was the seventh-highest seller among all vehicles in India last year with 96,989 units.
Hyundai also sold 73,537 units of Creta in Russia last year, making it the best-selling model with a 28 percent share in the country’s SUV segment.
Between January and April this year, 25,768 units of Creta were sold in Russia, gaining 29 percent from the same period last year.
Indian drivers, according to analysts, prefer SUVs with tall vehicle bodies like Creta because of the often subpar road conditions in India.
Indian buyers currently must wait for up to nine months before getting their Creta delivered due to the auto industry's chip shortage and the skyrocketing demand for the model.
India’s auto magazine CarDekho noted that while the Hyundai Creta is cheaper than Tata’s Harrier SUV, it offers more functions.


Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nikkei 225 Hits Record High Above 56,000 After Japan Election Boosts Market Confidence
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Asian Markets Surge as Japan Election, Fed Rate Cut Bets, and Tech Rally Lift Global Sentiment
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
UK Starting Salaries See Strongest Growth in 18 Months as Hiring Sentiment Improves
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 



